• Aucun résultat trouvé

Genetics: Familial melanoma

N/A
N/A
Protected

Academic year: 2022

Partager "Genetics: Familial melanoma"

Copied!
1
0
0

Texte intégral

(1)

Vol 56: january • janVier 2010 Canadian Family PhysicianLe Médecin de famille canadien

31

Practice

Dermacase

Can you identify this condition?

Adele Chedraoui

MD

Ossama Abbas

MD

Salah Salman

MD

A

7-year-old boy presented with an asymptom- atic skin-coloured to yellowish, soft to semi- firm, slightly cystic dermal plaque, 2 to 3 cm in diameter, on the left temporal, somatic aspect of the scalp, which had been there since birth.

A minute dimple was noted within the plaque.

There was no history of any preceding perinatal trauma. The patient was healthy and taking no drugs. His family history was noncontributory.

The most likely diagnosis is

1. Epidermal inclusion cyst 2. Dermoid cyst

3. Nevus sebaceus 4. Meningoencephalocele

Answer on page 33

Genetics

Familial melanoma

Carol Cremin

MSc

Sean M. Blaine

MD

Judith Allanson

MD

Heather Dorman

MSc

Clare A. Gibbons

MS

Christina Honeywell

MSc

Wendy S. Meschino

MD

Joanne Permaul June C. Carroll

MD

A

pproximately 1 in 75 people in North America will develop melanoma, and the presence of 1 or more of the following increases the risk 10-fold:

atypical moles, more than 100 typical moles, or a family history of 2 first-degree relatives with mela- noma. Five percent to 12% of melanomas occur in individuals with a familial predisposition, but not all are part of a hereditary melanoma syndrome. Two genes, cyclin-dependent kinase (CDK) inhibitor 2A and CDK4, account for up to half the cases of heredi- tary melanoma. Mutations in these genes are asso- ciated with a substantial lifetime risk of melanoma.

Bottom line. High-risk families can be offered referral for genetic counseling. Although genetic testing is available, there is a lack of consensus on how results should alter clinical recommenda- tions. Melanoma prevention and surveillance rec- ommendations should be based on the patient’s personal and family history.

The complete Gene Messenger—Familial Melanoma by the GenetiKit research team is avail- able on CFPlus.*Past Gene Messenger articles can be accessed on-line at www.cfp.ca. On the home page, click on Collections in the left-hand menu, then click on Genetics.

Competing interests None declared

The GenetiKit research team, a group of family physicians, genetic counselors and geneticists, designed the Gene Messenger series to pro- vide practical information to help family physicians and their patients make informed choices about rapidly emerging genetic discoveries.

The series is a collection of up-to-date, definitive, short reviews on genetics topics that have made headlines, and offers recommendations regarding referral for genetic services or testing.

acknowledgment

Funding was provided by the Canadian Institutes of Health Research.

CFPlus

GO

The English translation of this article, is available at www.cfp.ca. Click on CFPlus to the right of the article or abstract.

*The Gene Messenger on familial melanoma is available at www.cfp.ca. Go to the full text of this article on-line, then click on CFPlus in the menu at the top right-hand side of the page.

GENE MESSENGER

For more information on genetics topics, see www.mtsinai.on.ca/FamMedGen/

Références

Documents relatifs

7,8 Given that family physicians are a pre- ferred source of health information and the most com- mon treatment provider for mental health complaints, 9,10

Treating all members of a family does not necessarily add much to the fundamental relationship in medicine, which is the relationship between doctor and

If the prin- ciple that family doctors should follow all members of a family is perceived as an obligation, doctors will feel compelled to take on patients they

The GenetiKit research team, a group of family physicians, genetic counselors and geneticists, designed the Gene Messenger series to pro- vide practical information to help

The GenetiKit research team, a group of family physicians, genetic counselors and geneticists, designed the Gene Messenger series to pro- vide practical information to help

OBJECTIVE To ascertain the opinions of family physicians about medication adherence in patients with chronic diseases and the role of community pharmacists in improving adherence

The GenetiKit research team, a group of family physicians, genetic counselors and geneticists, designed the Gene Messenger series to pro- vide practical information to help

The GenetiKit research team, a group of family physicians, genetic counselors and geneticists, designed the Gene Messenger series to pro- vide practical information to help